Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy

Bulletin of Experimental Biology and Medicine

Volumn 146, Issue 3, 2008, Pages 348-350

  Gorobets, L N ^a  

^a Federal Agency for Health Care and Social Development   (Russian Federation)

Author keywords

Antipsychotic therapy; Gender factor; Leptin; Neuroleptic obesity

Indexed keywords

CLOZAPINE; LEPTIN; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; GENDER; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SCHIZOPHRENIA; WAIST HIP RATIO; WEIGHT CHANGE; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; FEMALE; HUMANS; LEPTIN; MALE; OBESITY; RISPERIDONE; SCHIZOPHRENIA, PARANOID; SEX FACTORS; YOUNG ADULT;

EID: 58249140051     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0294-0     Document Type: Article

References (11)

1. L. N. Gorobets, Sots. Klin. Psikhiatr., 15, No. 1, 89-99 (2005).
2. L. N. Gorobets, Neuroendocrine Dysfunctions and neuroleptic Therapy [in Russian], Moscow (2007).
3. L. Lavin, Endocrinology [in Russian], Moscow (1999).
4. S. N. Mosolov, Fundamentals of Psychopharmacotherapy [in Russian], Moscow (1996).
5. S. N. Mosolov, Progress in Therapy of Mental Diseases [in Russian], Moscow (2002), P. 21.
6. R. S. Ahima, D. Prabakaran, C. Mantzoros, et al., Nature, 382, 250-252 (1996).
7. T. Bromel, W. F. Blum, A. Ziegler, et al., Mol. Psychiatry, 3, No. 1, 76-80 (1998).
8. K. L. Houseknecht, C. Mantzoros, R. Kuliawat, et al., Diabetes, 45, No. 11, 1638-1643 (1996).
9. C. E. Koro, D. O. Fedder, G. J. L'Italien, et al., Br. Med. J., No. 325, 243 (2002).
10. T. J. Lauterio, M. J. Davies, M. DeAngelo, et al., Obes. Res., 7, No. 5, 498-505 (1999).
11. K. I. Melkersson, A. L. Hulting, and K. E. Brismar, J. Clin. Psychiatry, 61, No. 10, 742-749 (2000).